Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0480-7062 Perampanel Perampanel Teva Pharmaceuticals, Inc. TABLET, FILM COATED CIII 2025-05-29
0480-7063 Perampanel Perampanel Teva Pharmaceuticals, Inc. TABLET, FILM COATED CIII 2025-05-29
0480-7065 Perampanel Perampanel Teva Pharmaceuticals, Inc. TABLET, FILM COATED CIII 2025-05-29
0480-7066 Perampanel Perampanel Teva Pharmaceuticals, Inc. TABLET, FILM COATED CIII 2025-05-29
0480-7067 Perampanel Perampanel Teva Pharmaceuticals, Inc. TABLET, FILM COATED CIII 2025-05-29
0480-7068 Perampanel Perampanel Teva Pharmaceuticals, Inc. TABLET, FILM COATED CIII 2025-05-29
62856-272 Fycompa perampanel Eisai Inc. TABLET CIII 2012-10-22
62856-274 Fycompa perampanel Eisai Inc. TABLET CIII 2012-10-22
62856-276 Fycompa perampanel Eisai Inc. TABLET CIII 2012-10-22
62856-278 Fycompa perampanel Eisai Inc. TABLET CIII 2012-10-22
62856-280 Fycompa perampanel Eisai Inc. TABLET CIII 2012-10-22
62856-282 Fycompa perampanel Eisai Inc. TABLET CIII 2012-10-22
62856-290 Fycompa perampanel Eisai Inc. SUSPENSION CIII 2016-04-30
69616-272 Fycompa perampanel Catalyst Pharmaceuticals, Inc. TABLET CIII 2024-01-02
69616-274 Fycompa perampanel Catalyst Pharmaceuticals, Inc. TABLET CIII 2024-01-02
69616-276 Fycompa perampanel Catalyst Pharmaceuticals, Inc. TABLET CIII 2024-01-02
69616-278 Fycompa perampanel Catalyst Pharmaceuticals, Inc. TABLET CIII 2024-01-02
69616-280 Fycompa perampanel Catalyst Pharmaceuticals, Inc. TABLET CIII 2024-01-02
69616-282 Fycompa perampanel Catalyst Pharmaceuticals, Inc. TABLET CIII 2024-01-02
69616-290 Fycompa perampanel Catalyst Pharmaceuticals, Inc. SUSPENSION CIII 2024-01-02



 [EPC] Established Pharmacological Classification 

Loading full table content...